CD4(+)CD25(+) T cells facilitate the induction of T cell anergy
- PMID: 11591749
- DOI: 10.4049/jimmunol.167.8.4271
CD4(+)CD25(+) T cells facilitate the induction of T cell anergy
Abstract
T cell anergy is characterized by the inability of the T cell to produce IL-2 and proliferate. It is reversible by the addition of exogenous IL-2. A similar state of unresponsiveness is observed when the proliferative response of murine CD4(+)CD25(-) T cells is suppressed in vitro by coactivated CD4(+)CD25(+) T cells. We have developed a suppression system that uses beads coated with anti-CD3 and anti-CD28 Abs as surrogate APCs to study the interaction of CD4(+)CD25(+) and CD4(+)CD25(-) T cells in vitro. CD4(+)CD25(+) T cell-induced suppression, in this model, was not abrogated by blocking the B7-CTLA-4 pathway. When the CD4(+)CD25(-) T cells were separated from the CD4(+)CD25(+) suppressor cells after 24 h of coactivation by the Ab-coated beads, the CD4(+)CD25(-) T cells were unable to proliferate or to produce IL-2 upon restimulation. The induction of this anergic phenotype in the CD4(+)CD25(-) T cells correlated with the up-regulated expression of the gene related to anergy in lymphocytes (GRAIL), a novel anergy-related gene that acts as a negative regulator of IL-2 transcription. This system constitutes a novel mechanism of anergy induction in the presence of costimulation.
Similar articles
-
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.J Immunol. 2001 Oct 15;167(8):4245-53. doi: 10.4049/jimmunol.167.8.4245. J Immunol. 2001. PMID: 11591746
-
CD4+CD25high regulatory cells in human peripheral blood.J Immunol. 2001 Aug 1;167(3):1245-53. doi: 10.4049/jimmunol.167.3.1245. J Immunol. 2001. PMID: 11466340
-
A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.J Immunol. 2002 Oct 1;169(7):3710-6. doi: 10.4049/jimmunol.169.7.3710. J Immunol. 2002. PMID: 12244164
-
The contributions of T-cell anergy to peripheral T-cell tolerance.Immunology. 2001 Jul;103(3):262-9. doi: 10.1046/j.1365-2567.2001.01250.x. Immunology. 2001. PMID: 11454055 Free PMC article. Review. No abstract available.
-
T cell anergy and costimulation.Immunol Rev. 2003 Apr;192:161-80. doi: 10.1034/j.1600-065x.2003.00009.x. Immunol Rev. 2003. PMID: 12670403 Review.
Cited by
-
Molecular mechanisms of treg-mediated T cell suppression.Front Immunol. 2012 Mar 21;3:51. doi: 10.3389/fimmu.2012.00051. eCollection 2012. Front Immunol. 2012. PMID: 22566933 Free PMC article.
-
CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.Immunology. 2007 Apr;120(4):447-55. doi: 10.1111/j.1365-2567.2007.02544.x. Epub 2007 Jan 17. Immunology. 2007. PMID: 17244157 Free PMC article.
-
Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Immunol Res. 2013 Dec;57(1-3):70-80. doi: 10.1007/s12026-013-8451-6. Immunol Res. 2013. PMID: 24222275 Review.
-
Immunotherapy of malignant brain tumors.Immunol Rev. 2008 Apr;222:70-100. doi: 10.1111/j.1600-065X.2008.00603.x. Immunol Rev. 2008. PMID: 18363995 Free PMC article. Review.
-
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease.Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10398-403. doi: 10.1073/pnas.0403342101. Epub 2004 Jul 2. Proc Natl Acad Sci U S A. 2004. PMID: 15235129 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous